Target / Biomarker
Discovery & Validation
Euretos is an AI (Artificial Intelligence) platform used by pre-clinical researchers for in-silico discovery & validation of targets and biomarkers. World leading pharma, biotech and academic institutions use it to accelerate their research. Available as subscription, consulting service or direct access
EURETOS AI PLATFORM
In Silico Multi Omics
Drive your in vitro and in vivo research by in silico multi omics analysis. Ask Euretos and evaluate how molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology.
FIND OUT MORE
We are hiring! Biological Data Scientist / Research ConsultantThursday 27 February 2020
Biological Data Scientist / Research Consultant Would you like to get involved at the forefront of applying AI & big data technology in life sciences research and work with the leading pharma, biotech and research institutions worldwide? I ...
Euretos presenting in the Scale-Up track at the Innovation for Health conferenceMonday 03 February 2020
Arie Baak, co-founder of Euretos, will be presenting at the Innovation for Health conference. This year’s event will take place in Rotterdam and Euretos will present as part of the Scale-Up track, February 13th at 11:30 in the Hudag Room. In ...
Prof David Webb (The Scripps Research Institute)
“The Euretos AI Platform is nothing less than an in silico way to save all drug and biotech researchers an infinite amount of blood, sweat and tears by providing
them with a powerful knowledge discovery platform.
The Euretos AI Platform allows the researcher to rapidly assess whether a given target, research area, etc., is related, even distantly, to another such entity thus allowing one to uncover hidden connections, leading to new knowledge.In the drug discovery arena, this thing is a gold mine.